Abstract: 26 27
Estrogen signaling pathways regulate cellular processes such as proliferation and 28 differentiation, and if deregulated, are involved in several human pathologies. Post-29 translational modifications (PTMs) play important roles in estrogen signaling pathways. This 30 review focuses on recent findings pertinent to arginine methylation of non-histone proteins 31
and their implications in estrogen signaling. We describe protein arginine methyltransferases 32 and demethylases, the role of methylarginine proteins in estrogen action and cross-talk with 33
other PTMs such as phosphorylation and lysine methylation. The relationships between 34 various PTMs form a specific code which might play an important role in hormone signaling. 35
In addition, deregulations of arginine methylation or of enzymes responsible for these 36 modifications could be key events in estrogen-dependent cancers such as breast cancer. 37 38 inserm-00452350, version 1 -2 Feb 2010 these cofactors may influence complex formation, enzymatic activity, subcellular localization, 113 and stability, leading to a subtle regulation of ER-mediated transcription (Figure 1) . 114 SRC-3: p/CIP/AIB1/SRC-3 is a member of the p160 coactivator family involved in CARM1 115 and PRMT1 recruitment to ER target genes [7] . SRC-3 (steroid receptor coactivator-3) 116 protein levels are amplified in breast cancer and associated with poor prognosis [21, 22] . In 117 fact, studies classified SRC-3 as an authentic oncogene [23, 24] . Two independent groups 118 found that CARM1 modifies SRC-3 [25, 26] , methylating it at the C-terminal region which 119 contains the p300 and CARM1-binding sites. SRC-3 methylation, which is induced by 120 estradiol, leads to the dissociation of CBP and CARM1 from SRC-3. Moreover, SRC-3 121 arginine methylation reduces its stability and causes an increase in its turnover. These results 122
show that arginine methylation is implicated in the regulation of coregulator stability in 123 response to estradiol. In addition to this role, arginine methylation also regulates the balance 124 between coactivator complex assembly and disassembly. Studies suggest that repetitive 125 association and dissociation of steroid receptors and coactivators from their target promoters 126 may be required to maintain an activated state of transcription [6] . Altogether, these results 127 highlight coactivator methylation as an important regulatory mechanism in hormonal 128 signaling. 129 CBP/p300: Recently, Lee et al. reported that p300 is methylated by CARM1 at R2142 which 130 is located within the C-terminal GRIP1 binding domain. Interestingly, methylation of R2142 131 inhibits the interaction between p300 and GRIP1 whereas PADI 4 removes this methylation 132 mark, thereby enhancing the p300-GRIP1 interaction. These methylation and demethylation 133 events alter the conformation and activity of the coactivator complex and regulate estrogen 134 receptor-mediated transcription [27] . This provides another example of arginine methylation 135 regulating coactivator complex assembly, conformation and function. 136 inserm-00452350, version 1 -2 Feb 2010 PGC-1 : PGC-1α (peroxisome proliferator-activated receptor gamma coactivator 1 alpha) 137 serves as a coactivator for several nuclear receptors, including ER , as well as other 138 transcription factors, such as nuclear respiratory factor 1 (NRF-1). Expression of PGC-1α is 139 induced by a variety of physiological stimuli that regulate metabolic activity, such as 140 exposure to cold, exercise, and fasting. PGC-1α regulates metabolic processes by affecting 141 genes involved in mitochondrial biogenesis, respiration and gluconeogenesis. Teyssier et al. 142 showed that the C-terminal region of PGC-1α is methylated by PRMT1 at one or more sites 143 within a glutamate and arginine rich region. PGC-1α coactivator activity and the ability of 144 PGC-1α to induce expression of target genes are both compromised by mutation of modified 145 arginine residues of PGC-1α or as a result of reduced PRMT1 levels by siRNA. Because 146 inhibition of PRMT1 leads to inhibition of the expression of some PGC-1α target genes 147 involved in mitochondrial biogenesis, it is tempting to speculate a role for PRMT1 in this 148 regulatory pathway [28] . However, the binding partners of methylated PGC-1α remain to be 149 determined. 150 RIP140: RIP140 (Receptor Interacting Protein of 140 kDa) is a well-known ER hormone-151 dependent binding corepressor [8] . In vitro and in vivo arginine methylation of RIP140 by 152 PRMT1 has been described in 3T3-L1 adipocytes [29] , and liquid chromatography-tandem 153 mass spectroscopy identified that arginine methylation occurs on R240, R650, and R948 as a 154 mono-methyl mark, suppressing RIP140 repressive activity by two mechanisms. First, 155 methylation of R240, located in the HDAC3 interaction domain of RIP140, impairs its 156 interaction with HDAC3, reducing its repressive function. Second, arginine methylation of the 157 three sites increases RIP140's interaction with CRM1, a component of the export machinery; 158 this leads to RIP140 export to the cytoplasm, thereby reducing its nuclear repressive function. 159
So far, RIP140 arginine methylation links to adipocyte differentiation in a physiological 160 context. RIP140 expression enhances fat accumulation in differentiated adipocytes cells byinhibiting lipolysis enzyme expression, whereas a constitutive hypermethylated mutant 162 (where arginine is replaced by phenylalanine) failed to exert an effect on fat accumulation 163 because of reduced repressor activity [29] . Because RIP140 repressive activity is inhibited by 164 arginine methylation and because RIP140 is a key factor in estrogen signaling, it will be of 165 interest to verify whether RIP140 arginine methylation plays a role in estrogen genomic and 166 non-genomic pathways. 
Concluding remarks 309
Arginine methylation impacts various levels of regulation in estrogen signaling, and thereby 310 appears to be a key regulatory event in genomic and non-genomic estrogen actions. In and it seems rather that histone citrunillation simply interferes with methylation of arginine 349 residues. The first histone demethylase removing asymmetrical dimethylation at arginine 2 of 350 histone H3 and symmetrical dimethylation at arginine 3 of histone H4 is the Jumonji domain-351 containing 6 protein (JMJD6) [69] . However, no publication has confirmed these results and, 352 very recently, the Bottger's group demonstrated that JMJD6 is a lysine hydroxylase involved 353 in RNA splicing indicating that demethylation of methylarginine residues is not its major 354 activity [70] . Altogether, this suggests that additional arginine demethylases remain to be 355 
